Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in GALT — Galectin Therapeutics Inc

CIK 72971 SAN FRANCISCO, CA
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$216,645
+$199,072 QoQ
Shares Held
46,691
+641.2% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 98 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. GALT ranks #244 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in GALT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $216,645 46,691
2026-03-31 $17,573 6,299
2025-12-31 $17,018 4,091
2025-09-30 $17,345 4,091
2025-06-30 $9,202 4,362
2025-03-31 $14,172 11,618
2024-12-31 $22,401 17,366
2024-09-30 $39,533 14,376
2024-06-30 $32,470 14,368
2024-03-31 $17,335 7,254
2023-12-31 $12,585 7,582
2023-09-30 $15,429 8,037
2023-06-30 $7,845 5,449
2023-03-31 $54,972 26,178
2022-12-31 $7,241 6,409
2022-09-30 $13,889 8,522
2022-06-30 $11,171 8,528
2022-03-31 $13,691 8,504
2021-12-31 $17,601 8,503
2021-09-30 $32,967 8,497
2021-06-30 $38,528 12,040
2021-03-31 $44,111 20,328
2020-12-31 $216,864 96,815
2020-09-30 $152,840 57,244
2020-06-30 $207,913 67,946
2020-03-31 $89,488 45,658